France’s Nicox (EPA: ALCOX) has announced that daily dosing of NCX 470 0.1%, a novel nitric oxide (NO)-donating bimatoprost ...

Celldex Therapeutics shares fell as much as 13% on Wednesday, after it posted mixed top-line results from its ongoing Phase II study of barzolvolimab in eosinophilic esophagitis (EoE), a chronic ...

German gene therapies developer VeonGen Therapeutics today revealed that the US Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to VG801, its ...

Danish allergy immunotherapy specialist ALK Abello today posted financial results which pleased investors, with its shares rising 6.2% to 199.50 kroner.

The UK’s NHS Business Services Authority's annual 'Prescribing for Diabetes - England 2015/16 to 2024/25' report reveals that diabetes treatments now account for 15% of all NHS prescription spending, ...

For what is reportedly the first time in decades, the American Academy of Pediatrics (AAP) has contradicted the US Centers for Disease Control and Prevention (CDC) over its recommended immunization ...

VantAI, a specialist in generative AI for proximity drug discovery, and Halda Therapeutics, a company focused on regulated ...

Japanese ophthalmology major Santen Pharmaceutical has licensed the Asia rights to Chinese biopharma RemeGen’s ...

Swiss pharma company Idorsia announced that its novel dual endothelin receptor antagonist (ERA), Tryvio (aprocitentan), has ...

Elix has announced that fellow Japanese firm Kyorin Pharmaceutical has adopted Elix Discovery, its proprietary AI-powered ...

PTC Therapeutics yesterday revealed that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL ...

Australia’s Neurizon Therapeutics, a biotech advancing innovative treatments for neurodegenerative diseases, has reported positive top-line results from the Open-Label Extension (OLE) study of its ...